SALLY DAVIDSON: Open Payments
NPI 1598429003 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,909 in 110 payments from 19 companies in 2025. Trend: 2023 $272 · 2024 $1,166 · 2025 $1,909
Food & beverage: $1,805Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $539 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 28 | $345 |
| Janssen Biotech, Inc. | 10 | $324 |
| Phathom Pharmaceuticals, Inc. | 15 | $172 |
| GENZYME CORPORATION | 7 | $151 |
| Ardelyx, Inc. | 4 | $78 |
| Gilead Sciences, Inc. | 2 | $50 |
| Sandoz Inc. | 2 | $40 |
| Organon LLC | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
Products named: XIFAXAN, TREMFYA, RINVOQ, VOQUEZNA, LINZESS, DUPIXENT, CREON, IBSRELA.
Industry payments across SC — which companies pay providers there.
